Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1743-2022Class III

BIOPHEN UFH Control Plasma

Aniara Diagnostica LLC / initiated 2022-06-28 / Terminated / root cause: labeling and UDI

Aniara Diagnostica LLC began a recall of BIOPHEN UFH Control Plasma on . FDA classified it as Class III and gives the reason as "Incorrect product labeling was included in the package". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1743-2022
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Aniara Diagnostica LLC
Product
BIOPHEN UFH Control Plasma
Product code
GGN Plasma, Coagulation Control
Reason for recall
Incorrect product labeling was included in the package.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
A recall notification letter was issued on August 3, 2022 to impacted consignees. Consignees were informed that the product is packaged with the incorrect insert ("flyer"). The recalling firm instructs consignees to destroy the included incorrect insert and use the attached correct insert. An Awareness Acknowledgement Form should be completed and returned to the recalling firm acknowledging that the information was received and the incorrect inserts were destroyed.
Quantity in commerce
13 units (1 unit is 1 box)
Distribution
Distribution in US - IL and MI
Product codes and lots
UDI-DI (GTIN): 03663537008290 Reference No.: 223101; Lot Code: FA2035

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1743-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1743-2022Class IIITerminatedVoluntary: Firm initiated